Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy (PIR-008/K)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Desitin Arzneimittel GmbH
ClinicalTrials.gov Identifier:
NCT01519856
First received: March 12, 2010
Last updated: January 28, 2016
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)